未登录 分享 收藏
分享 收藏
分享 收藏
Early- Stage Rectal Cancer: Clinical and Pathologic Prognostic Markers of Time to Local Recurrence and Overall Survival After Resection Patel, Sagar A.; Chen, Yu-Hui; Hornick, Jason L.; Catalano, Paul; Nowak, Jonathan A.; Zukerberg, Lawrence R.; Bleday, Ronald; Shellito, Paul C.; Hong, Theodore S.; Mamon, Harvey J. 分享 收藏
分享 收藏
Phase I/II study of neoadjuvant bevacizumab, erlotinib and 5-fluorouracil with concurrent external beam radiation therapy in locally advanced rectal cancer Blaszkowsky, L. S.; Ryan, D. P.; Szymonifka, J.; Borger, D. R.; Zhu, A. X.; Clark, J. W.; Kwak, E. L.; Mamon, H. J.; Allen, J. N.; Vasudev, E.; Shellito, P. C.; Cusack, J. C.; Berger, D. L.; Hong, T. S. 分享 收藏
分享 收藏
A study of neoadjuvant bevacizumab with standard chemoradiation versus chemoradiation alone in locally advanced rectal cancer Willett, Christopher G.; Duda, Dan G.; Ancukiewicz, Marek; Shah, Mira; Czito, Brian; Bentley, Rex; Poleski, Martin; Fujita, Hiroshi; Lauwers, Gregory Y.; Carroll, Madeline; Tyler, Douglas; Mantyh, Christopher; Shellito, Paul; Chung, Daniel C.; Clark, Jeffrey W.; Jain, Rakesh K. 分享 收藏
Plasma soluble VEGFR1 is a potential dual biomarker of response and toxicity for bevacizumab with chemoradiation in locally advanced rectal cancer Duda, Dan G.; Willett, Christopher G.; Ancukiewicz, Marek; di Tomaso, Emmanuelle; Shah, Mira; Czito, Brian G.; Bentley, Rex; Poleski, Martin; Lauwers, Gregory Y.; Carroll, Madeline; Tyler, Douglas; Mantyh, Christopher; Shellito, Paul; Clark, Jeffrey W.; Jain, Rakesh K. 分享 收藏
Direct Evidence that Bevacizumab, an Anti-VEGF Antibody, Up-regulates SDF1α, CXCR4, CXCL6, and Neuropilin 1 in Tumors from Patients with Rectal Cancer Xu, Lei; Duda, Dan G.; di Tomaso, Emmanuelle; Ancukiewicz, Marek; Chung, Daniel C.; Lauwers, Gregory Y.; Samuel, Rekha; Shellito, Paul; Czito, Brian G.; Lin, Pei-Chun; Poleski, Martin; Bentley, Rex; Clark, Jeffrey W.; Willett, Christopher G.; Jain, Rakesh K. 分享 收藏
分享 收藏
Practice parameters for the surgical treatment of ulcerative colitis Cohen, JL; Strong, SA; Hyman, NH; Buie, WD; Dunn, GD; Ko, CY; Fleshner, PR; Stahl, TJ; Kim, DG; Bastawrous, AL; Perry, WB; Cataldo, PA; Rafferty, JF; Ellis, CN; Rakinic, J; Gregorcyk, S; Shellito, PC; Kilkenny, JW; Ternent, CA; Koltun, W; Tjandra, JJ; Orsay, CP; Whiteford, MH; Penzer, JR 分享 收藏
Practice parameters for the treatment of perianal abscess and fistula-in-ano (Revised) Whitfford, MH; Kilkenny, J; Hyman, N; Buie, WD; Cohen, J; Orsay, C; Dunn, G; Perry, WB; Ellis, CN; Rakinic, J; Gregorcyk, S; Shellito, P; Nelson, R; Tiandra, JJ; Newstead, G 分享 收藏
Practice parameters for the management of hemorrhoids (revised) Cataldo, P; Ellis, CN; Gregorcyk, S; Hyman, N; Buie, WD; Church, J; Cohen, J; Fleshner, P; Kilkenny, J; Ko, C; Levien, D; Nelson, R; Newstead, G; Orsay, C; Perry, WB; Rakinic, J; Shellito, P; Strong, S; Ternent, C; Tjandra, J; Whiteford, M 分享 收藏
Practice parameters for the management of anal fissures (revised) Orsay, C; Rakinic, J; Perry, WB; Hyman, N; Buie, D; Cataldo, P; Newstead, G; Dunn, G; Rafferty, J; Ellis, CN; Shellito, P; Gregorcyk, S; Ternent, C; Kilkenny, J; Tjandra, J; Ko, C; Whiteford, M; Nelson, R 分享 收藏
分享 收藏
分享 收藏
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer (vol 10, pg 145, 2004) Willett, CG; Boucher, Y; di Tomaso, E; Duda, DG; Munn, LL; Tong, RT; Chung, DC; Sahani, DV; Kalva, SP; Kozin, SV; Mino, M; Cohen, KS; Scadden, DT; Hartford, AC; Fischman, AJ; Clark, JW; Ryan, DP; Zhu, AX; Blaszkowsky, LS; Chen, HX; Shellito, PC; Lauwers, GY; Jain, RK 分享 收藏
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer Willett, CG; Boucher, Y; di Tomaso, E; Duda, DG; Munn, LL; Tong, RT; Chung, DC; Sahani, DV; Kalva, SP; Kozin, SV; Mino, M; Cohen, KS; Scadden, DT; Hartford, AC; Fischman, AJ; Clark, JW; Ryan, DP; Zhu, AX; Blaszkowsky, LS; Chen, HX; Shellito, PC; Lauwers, GY; Jain, RK 分享 收藏
分享 收藏